Join Growin Stock Community!

Prenetics global limitedPRENW.US Overview

US StockHealthcare
(No presentation for PRENW)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

PRENW AI Insights

PRENW Overall Performance

PRENW AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

PRENW Recent Performance

-

Prenetics global limited

0.05%

Avg of Sector

-0.31%

S&P500

PRENW PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

PRENW Key Information

PRENW Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

PRENW Profile

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Price of PRENW

PRENW FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

PRENW Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-3.31
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
47.16%
Net Margin
-67.43%
Revenue Growth (YoY)
170.08%
Profit Growth (YoY)
129.79%
3-Year Revenue Growth
-33.38%
3-Year Profit Growth
-33.09%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-3.31
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
47.16%
Net Margin
-67.43%
Revenue Growth (YoY)
170.08%
Profit Growth (YoY)
129.79%
3-Year Revenue Growth
-33.38%
3-Year Profit Growth
-33.09%

  • When is PRENW's latest earnings report released?

    The most recent financial report for Prenetics global limited (PRENW) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating PRENW's short-term business performance and financial health. For the latest updates on PRENW's earnings releases, visit this page regularly.

  • What is the operating profit of PRENW?

    According to the latest financial report, Prenetics global limited (PRENW) reported an Operating Profit of -6.16M with an Operating Margin of -26.17% this period, representing a growth of 47.8% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is PRENW's revenue growth?

    In the latest financial report, Prenetics global limited (PRENW) announced revenue of 23.56M, with a Year-Over-Year growth rate of 202.84%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does PRENW have?

    At the end of the period, Prenetics global limited (PRENW) held Total Cash and Cash Equivalents of 13.26M, accounting for 0.07 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does PRENW go with three margins increasing?

    In the latest report, Prenetics global limited (PRENW) did not achieve the “three margins increasing” benchmark, with a gross margin of 37.2%%, operating margin of -157.97%%, and net margin of -155.81%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess PRENW's profit trajectory and future growth potential.

  • Is PRENW's EPS continuing to grow?

    According to the past four quarterly reports, Prenetics global limited (PRENW)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.53. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What are the PEG ratio and PE ratio of PRENW?

    The latest valuation data shows Prenetics global limited (PRENW) has a Price-To-Earnings (PE) ratio of -1.13 and a Price/Earnings-To-Growth (PEG) ratio of 0.01. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.